Carisoprodol and Aspirin (Eon Labs, Inc.)
Welcome to the PulseAid listing for the Carisoprodol and Aspirin drug offered from Eon Labs, Inc.. This Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eon Labs, Inc. |
NON-PROPRIETARY NAME: | Carisoprodol and Aspirin |
SUBSTANCE NAME: | CARISOPRODOL; ASPIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1996-04-25 |
END MARKETING DATE: | 0000-00-00 |
Carisoprodol and Aspirin HUMAN PRESCRIPTION DRUG Details:
Item Description | Carisoprodol and Aspirin from Eon Labs, Inc. |
LABELER NAME: | Eon Labs, Inc. |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 200; 325(mg/1; mg/1) |
START MARKETING DATE: | 1996-04-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0185-0724_501b39a2-0b88-4277-89a1-45b61cdad1bf |
PRODUCT NDC: | 0185-0724 |
APPLICATION NUMBER: | ANDA040116 |
Other CARISOPRODOL; ASPIRIN Pharmaceutical Manufacturers / Labelers: